Biochemistry, Genetics & Applications of Bacillus thuringiensis israelensis and Bacillus sphaericus
نام نخستين پديدآور
edited by Huguette Barjac, Donald J. Sutherland.
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Dordrecht
نام ناشر، پخش کننده و غيره
Springer Netherlands
تاریخ نشرو بخش و غیره
1991
مشخصات ظاهری
نام خاص و کميت اثر
(336 pages)
یادداشتهای مربوط به مندرجات
متن يادداشت
1 Bacillus thuringiensis subsp. israelensis (B.t.i.).- 1 Discovery of Bacillus thuringiensis israelensis.- 1.1 Introduction.- 1.2 Geography, Climate, and Environmental Conditions.- 1.3 Detection and Isolation.- 2 Characterization and Prospective View of Bacillus thuringiensis israelensis.- 3 Parasporal Body of Bacillus thuringiensis israelensis: Structure, Protein Composition, and Toxicity.- 3.1 Introduction.- 3.2 Synthesis.- 3.3 Structure.- 3.4 Purification and Solubilization.- 3.5 Protein Composition.- 3.6 Toxicity.- 3.6.1 Intact or Solubilized Parasporal Body.- 3.6.2 The 27-kDa Protein.- 3.6.3 The 65-kDa Protein.- 3.6.4 The 128- and 135-kDa Proteins.- 3.6.5 Synergistic Interaction of Toxic Proteins.- 3.7 Mosquiticidal Parasporal Bodies of Other Subspecies of B. thuringiensis.- 3.8 Discussion.- 4 Mechanism of Action of Bacillus thuringiensis israelensis Parasporal Body.- 4.1 Introduction.- 4.2 Mechanism of Action.- 4.2.1 Receptors.- 4.2.2 Toxin Structure and Membrane Insertion.- 4.2.3 Colloid-Osmotic Lysis Theory.- 4.2.4 Toxin Oligomerization.- 4.3 Discussion.- 5 Genetics of Bacillus thuringiensis israelensis.- 5.1 Introduction.- 5.2 Genetic Exchange Systems.- 5.2.1 Transformation.- 5.2.2 Transduction.- 5.2.3 Plasmid Transfer.- 5.3 Plasmids and Crystal Toxin Production.- 5.3.1 Plasmids and Plasmid Curing Analysis.- 5.3.2 Location of the ?-endotoxin Gene.- 5.4 Cloning of the Crystal Toxin Gene(s).- 5.5 Genetics and Biochemistry of the Crystal Toxin.- 5.6 Conclusions.- 6 Cloning of Bacillus thuringiensis israelensis Mosquito Toxin Genes.- 6.1 Introduction.- 6.2 Early Confusion in Cloning B.t.i. Toxin Protein Genes.- 6.3 Current Picture of B.t.i. Toxin Protein Genes.- 6.4 Discussion.- 7 Transfer of the Bacillus thuringiensis israelensis Mosquiticidal Toxin Gene into Mosquito Larval Food Sources.- 7.1 Introduction.- 7.2 Assignment of Toxic Activity.- 7.3 Cloning of the Mosquito Toxin Gene.- 7.4 Mosquito and Black Fly Larval Food Sources.- 7.5 Introduction of the Mosquito Toxin Gene into Larval Food Sources.- 7.6 Safety Aspects.- 8 Potential for Improved Formulations of Bacillus thuringiensis israelensis through Standardization and Fermentation Development.- 8.1 Introduction.- 8.2 History.- 8.2.1 Background.- 8.2.2 Discovery and Early History.- 8.2.3 Standardizing and Measuring B.t. Products.- 8.2.3.1 Early Concepts.- 8.2.3.2 The Spore Count.- 8.3 Bioassays and the International Unit.- 8.3.1 Philosophical Differences between Bioassays of Chemical and Microbial Insecticides.- 8.3.2 Bioassays and the LC50.- 8.3.3 Choice of Insect Species for Bioassay.- 8.3.4 The International Unit.- 8.3.5 The de Barjac Protocol for B.t.i.: Its Design and Principles.- 8.3.5.1 Preparation of Stock Suspension of the Standard.- 8.3.5.2 Preparation of Suspension of the Test Samples.- 8.3.5.3 Specifications for Larvae Used in Assay.- 8.3.5.4 Reading the Assay.- 8.3.5.5 Evaluations of Assays and Their Reproducibility.- 8.4 Activity Ratios.- 8.4.1 Definition of Activity Ratios.- 8.4.2 Use and Significance of Activity Ratios.- 8.4.2.1 Tn/Hv Ratios of subspecies kurstaki.- 8.4.2.2 Cq/Aa Ratios of subspecies israelensis.- 8.4.2.3 Reproducibility of Activity Ratios in Fermentation Studies.- 8.5 Potential for Improvements in Production of the B.t.i. Toxin.- 8.5.1 Fermentation.- 8.5.1.1 Strain Selection.- 8.5.1.2 Aeration.- 8.5.1.3 Selection of Nutrients.- 8.5.2 Recovery.- 8.5.2.1 Spore-crystal Formulations.- 8.5.2.2 Viable Spore-free Formulations.- 8.6 Summary.- 8.6.1 Bioassays and the Production of B.t..- 8.6.2 Bioassays and the Future of B.t..- 9 Activity, Field Efficacy, and Use of Bacillus thuringiensis israelensis against Mosquitoes.- 9.1 Introduction.- 9.2 Laboratory Evaluation.- 9.2.1 Screening Procedures.- 9.2.2 Preliminary Screening.- 9.2.3 Species Specificity.- 9.2.4 Instar Susceptibility.- 9.2.5 Biotic and Abiotic Factors Influencing Activity.- 9.2.6 Delayed Effects.- 9.3 Field Evaluation and Efficacy Trials.- 9.3.1 Spectrum of Field Activity.- 9 3.1.1 Floodwater Mosquitoes.- 9.3.1.2 Anopheles Mosquitoes.- 9.3.1.3 Culex Mosquitoes.- 9.3.2 Persistence and Recycling.- 9.4 Impact on Nontarget Organisms.- 9.5 Microbial Larvicides in Integrated Control of Mosquitoes.- 10 Progress in the Biological Control of Black Flies with Bacillus thuringiensis israelensis, with Emphasis on Temperate Climates.- 10.1 Nature of the Black Fly Problem in Temperate Climates.- 10.2 Advent of B.t.i..- 10.3 Trends in Recent Research Efforts.- 10.4 Factors Affecting the Efficacy of B.t i. against Black Flies.- 10.4.1 Environmental Parameters.- 10.4.1.1 Discharge.- 10.4.1.2 Stream Profile.- 10.4.1.3 Turbidity.- 10.4.1.4 Pollutants.- 10.4.1.5 Water Temperature.- 10.4.1.6 pH.- 10.4.1.7 Degree of Vertical Mixing in the Water Column.- 10.4.1.8 Reduced Water Velocity Due to Negative Relief.- 10.4.1.9 Attachment of B.t.i. to Benthic Substrates/Sediments.- 10.4.1.10 Other Factors.- 10.4.2 Black Fly Parameters.- 10.4.2.1 Larval Age.- 10.4.2.2 Species.- 10.4.2.3 Feeding Behavior.- 10.4.3 Formulation Parameters.- 10.4.3.1 Particle Size.- 10.4.3.2 Powdered versus Liquid Formulations.- 10.4.3.3 Formulation Additives.- 10.4.4 Treatment Parameters.- 10.4.4.1 Concentration.- 10.4.4.2 Duration of Application.- 10.4.4.3 Preparation of Powdered Formulations.- 10.5 Lack of Correlation in Formulation Potency against Black Flies and Mosquitoes.- 10.6 Effect of B.t.i. on Black Fly Populations.- 10.7 Effect of B.t.i. on Nontarget Populations.- 10.7.1 Toxicity.- 10.7.2 Inducement of Drift.- 10.8 Treatment and Assessment Methodologies.- 10.8.1 Discharge Calculation.- 10.8.2 Treatment.- 10.8.3 Assessments of Black Fly Mortality.- 10.9 Product/Formulation Improvement.- 10.10 Area-control Programs.- 10.11 Possibility of Resistance.- 10.12 Research Priorities in Temperate Climates.- 10.13 Conclusions.- 11 Use of Bacillus thuringiensis israelensis for Onchocerciasis Control in West Africa.- 11.1 Introduction.- 11.2 The Search for Suitable B.t.i. Formulations.- 11.3 Operational Use of B.t.i. in the OCP.- 11.4 Discussion and Prospects.- 12 Mammalian Safety of Bacillus thuringiensis israelensis.- 12.1 Introduction.- 12.2 Source and Preparation of Cultures.- 12.3 Results and Discussion.- 12.3.1 Oral and Intraperitoneal Administration.- 12.3.2 Subcutaneous Injection.- 12.3.3 Aerosol Exposure.- 12.3.4 Intracerebral Injection.- 12.3.5 Clearance.- 12.3.6 Ocular Irritancy.- 12.4 Summary.- 12.5 Summary of Other Studies.- 2 Bacillus sphaericus.- 3 Introduction to the Study of Bacillus sphaericus as a Mosquito Control Agent.- 13.1 Introduction.- 13.2 History of Extant Strains.- 13.3 Future Strains.- 14 Classification of Bacillus sphaericus Strains and Comparative Toxicity to Mosquito Larvae.- 14.1 Introduction.- 14.2 Different Approaches to the Classification and Characterization of Toxic Strains.- 14.3 Comparative Toxicity of Various Serotypes.- 14.4 Distribution of the Larvicidal Strains and Activity Ratios.- 15 The Mosquito Larval Toxin of Bacillus sphaericus.- 15.1 Location of the Toxin in the Bacterial Cell.- 15.2 Biochemical Nature of the Toxin.- 15.3 Pathology in the Host.- 15.4 Host Range of the Toxin.- 15.5 Pathology of the Toxin in Cultured Cells.- 15.6 Comparison of the B. sphaericus Toxin with the B.t.i. Toxin.- 16 Genetics of Bacillus sphaericus.- 16.1 Introduction.- 16.2 Evidence of Genetic Heterogeneity within the Species B. sphaericus.- 16.3 Naturally Occurring Antibiotic Resistances in B. sphaericus.- 16.4 Auxotrophic Mutants of B. sphaericus.- 16.5 Transformation of B. sphaericus with Plasmid DNA.- 16.6 B sphaericus Mutants with Limited Restriction Endonuclease Activity.- 16.7 Evidence for the Existence of a Bsp 1593 Modification System.- 16.8 Conjugal Transfer of pAMssl in B. sphaericus 1593.- 16.9 Construction of Plasmid Vectors for Cloning in B sphaericus 1593.- 16.10 Cloning of B.
متن يادداشت
sphaericus Larvicidal Toxin Genes.- 17 Local Production of Bacillus sphaericus.- 17.1 Introduction.- 17.2 The Need for Local Production ofB. sphaericus.- 17.3 Growth and Cultivating Conditions for B. sphaericus.- 17.4 Formulation of B. sphaericus.- 17.5 Economics of Local Production of B. sphaericus.- 17.6 Conclusions.- 18 Persistence and Formulation of Bacillus sphaericus.- 18.1 Introduction.- 18.2 Factors Affecting Residual Activity.- 18.2.1 Definitions.- 18.2.2 Water Quality, Depth, and Feeding Behavior.- 18.2.3 Solar Radiation.- 18.2.4 Species Susceptibility.- 18.2.5 Recycling.- 18.3 Formulation: Field Efficacy.- 18.3.1 Granules.- 18.3.2 Flowable Concentrates.- 18.3.3 Sustained-release Formulations.- 18.3.4 Storage Considerations.- 18.4 Recommendations for Future Formulation Research.- 19 Formulations and Persistence of Bacillus sphaericus in Culex quinquefasciatus Larval Sites in Tropical Africa.- 19.1 Introduction.- 19.2 Field Evaluation.- 19.2.1 Wettable Powder 1593.- 19.2.2 Flowable Concentrate 2362.- 19.3 Bacteriological Tests.- 19.4 Discussion.- 19.4.1 Persistence of B. sphaericus in the Field.- 19.4.2 Recycling of B sphaericus in the Field.- 19.5 Conclusions.- 19.6 Summary.- 20 Field Trials of Bacillus sphaericus for Mosquito Control.- 20.1 Introduction.- 20.2 General Information on Field Trials.- 20.3 Field Trials against Culex.- 20.4 Field Trials against Aedes, Anopheles, Mansonia, andPsorophora.- 20.5 Discussion.- 21 Mammalian Safety of Bacillus sphaericus.- 21.1 Introduction.- 21.2 Source and Preparation of Cultures.- 21.3 Results and Discussion.- 21.3.1 Subcutaneous and Intraperitoneal Injection.- 21.3.2 Intradermal Injection.- 21.3.3 Ocular Irritancy.- 21.3.4 Intraocular Injection.- 21.3.5 Ocular Persistence.- 21.3.6 Intracerebral Injection.- 21.4 Summary of Other Studies.- 21.5 Conclusion.- 3 The Future.- 22 The Future of Bacterial Control of Mosquito and Black Fly Larvae.- 22.1 Introduction.- 22.2 Perspective for the Next Decade.- 22.2.1 Supportive Factors.- 22.2.2 Counterfactors.- 22.3 Prospects for the Future.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Life sciences.
موضوع مستند نشده
Morphology (Animals)
رده بندی کنگره
شماره رده
QR82
.
B3
نشانه اثر
E358
1991
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )